Cortechs.ai | Cortechs.ai Red Herring Top 100 North America winner

Cortechs.ai Red Herring Top 100 North America winner

Cortechs.ai recognized as a leading and promising North American startup for innovation and technology.

(San Diego, CA) June 13, 2016 – Cortechs.ai, the leading medical software innovator providing solutions for quantitative brain image analysis, is pleased to announce that it has been selected as a winner for Red Herring’s Top 100 North America award.

Since 1996, Red Herring has been selecting outstanding entrepreneurs and promising startup companies for their innovations and disruptive technologies across a variety of industries. Cortechs.ai joins a distinguished list of companies to be recognized by Red Herring that have gone on to change the way we live and work including Facebook, Twitter, Yahoo, Skype, Salesforce.com, YouTube and eBay.

“The entire team at Cortechs.ai is passionate about developing software solutions that dramatically improve the assessment of the human brain,” said Guri Stark, Cortechs.ai’ CEO.  “We are very excited to be recognized for our proven technological contributions, which provide physicians with innovative tools used in the evaluation of neurological conditions, such as Alzheimer’s disease, brain trauma, multiple sclerosis, epilepsy and brain development.”

Companies were evaluated by Red Herring editorial staff on both quantitative and qualitative criteria for financial performance, technological innovation and intellectual property, management quality, business model, customer footprint and market penetration. This assessment of potential is complemented by a review of the track record and standing of startups relative to their sector peers, allowing Red Herring to see past the “buzz” and make the list a valuable instrument of discovery and advocacy for the most promising new business models in North America.

“In 2016, selecting the top achievers was extremely difficult,” said Alex Vieux, publisher and CEO of Red Herring. “The variety, depth, disruption and traction we saw from the early stage companies to those with significant scale made it one of the toughest vintages to judge. The North America winners are representative of the amazing ecosystem that never ceases to astound, with new and experienced entrepreneurs continuing to push the barriers of innovation. As one of the winners, Cortechs.ai should be proud of its accomplishment under such strong competition.”

For more information about the Red Herring Top 100 North America award, please visit www.redherring.com/events/top-100/.

About Cortechs.ai
Cortechs.ai develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. Cortechs.ai’ cutting-edge brain imaging analysis provides neurologists, radiologists, and clinical researchers worldwide with a convenient and cost-effective means to quantify subcortical structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma and brain development. Please visit cortechs.ai for further information.

More Resources

09/16/2025

OnQ Prostate for Focal Therapy

Read how OnQ Prostate supports focal therapy by personalizing prostate cancer care for patients while minimizing the risks associated with it.

09/03/2025

Reimbursement Considerations for OnQ Prostate and Category III CPT Codes 0648T & 0649T

Learn how Cat. III CPT codes 0648T and 0649T apply to OnQ™ Prostate, offering guidance for accurate reporting, reimbursement, and building evidence for coverage

09/02/2025

Maximizing the Value of Prostate MRI for the Urologist

Even with expert radiologists or AI models at hand, the challenge remains: how can urologists improve seeing and interpreting cancer?

08/18/2025

Why Bigger Normative Databases Mean Better Brain Imaging

NeuroQuant® 5.2 compares patient brain MRI volumes to over 7,000 healthy scans, giving clinicians clear, percentile-based context for better assessments.

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T 

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.
Scroll to Top